Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -120,855 | -94,540 | -67,846 | -39,023 | -154,154 |
| Depreciation Amortization | 9,364 | 7,459 | 5,640 | 2,328 | 11,107 |
| Accounts receivable | 4,475 | 3,728 | 4,605 | 5,417 | 12,551 |
| Other Working Capital | -8,127 | -2,394 | 3,182 | 5,665 | -12,519 |
| Other Operating Activity | 34,952 | 18,463 | 7,194 | 226 | 14,790 |
| Operating Cash Flow | $-80,191 | $-67,284 | $-47,225 | $-25,387 | $-128,225 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | 2,902 |
| Purchase Sale Intangibles | -15,000 | N/A | N/A | N/A | -5,000 |
| Other Investing Activity | -15,000 | 0 | 0 | 0 | -5,005 |
| Investing Cash Flow | $-15,000 | $N/A | $N/A | $N/A | $-2,103 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 28,000 |
| Debt Issued | 43,670 | 38,668 | 5,000 | N/A | 14,529 |
| Debt Repayment | -51,000 | -51,000 | N/A | N/A | -50,375 |
| Common Stock Issued | 22,225 | 18,157 | 26,769 | 10,282 | 24,800 |
| Dividend Paid | -4,710 | -4,544 | -352 | -2,184 | -8,768 |
| Other Financing Activity | 60,456 | 43,554 | 10,707 | 19,761 | 24,553 |
| Financing Cash Flow | $70,641 | $44,835 | $42,124 | $27,859 | $32,739 |
| Beginning Cash Position | 83,365 | 83,365 | 83,365 | 83,365 | 180,954 |
| End Cash Position | 58,815 | 60,916 | 78,264 | 85,837 | 83,365 |
| Net Cash Flow | $-24,550 | $-22,449 | $-5,101 | $2,472 | $-97,589 |
| Free Cash Flow | |||||
| Operating Cash Flow | -80,191 | -67,284 | -47,225 | -25,387 | -128,225 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -3,098 |
| Free Cash Flow | -80,191 | -67,284 | -47,225 | -25,387 | -131,323 |